Does the immune system "know" how to
protect you, or does it have to be "taught"?
Availability of these products
There are over 2,000,000
chemicals of enormous variety, which the body must identify
in order to act against invaders. But how does the body know these
antigens -- "friend from foe"?
Answer: The immune system has to be "taught."
This is the story of transfer factors --
and how an amazing medical development that started in 1949
has been derailed by cheap, diluted alternatives ... and
what it will take to maximize the potential of this
promising disease-fighting approach.
ne of the great mysteries of advanced
animal physiology has been the ability of the immune system to
respond to so many different threats -- from foreign
cells to pathogenic microbes to toxic agents.
The antigens which the human immune system must recognize
to ward off or neutralize these invaders number in the millions.
Educating Your Immune Cells
If antibodies are not transferred, and TF itself does not directly create antibodies or attack antigens or their hosts, what is actually being transferrred? How does TF enliven the body's immune potential?
What has emerged since the work of H.S. Lawrence is an understanding of TF's as not mere nutrients. They are educators -- teaching the cell-mediated immune system to recognize specific antigens, and with it a knowledge of when they are present. This is probably why orthodox medicine is having problems embracing the TF model or approach to disease. It is a radical departure from the standard pharmacological models. TF's do not cure anything. Antigen-specific TF's do not eliminate the condition or agent behind the antigen they help their host identify. Instead, they work in an immunosupportive capacity to make the immune system "smarter," so that the body is better able to eliminate disease conditions on its own.
For years, alternative practitioners have encouraged patients with immune deficiencies to take commercial-sold colostrum, which are usually of bovine origin. In light of the function of transfer factors, we now understand how such colostrum, void as it is of specific-antigen information, would help some patients. Colostrum, even from cows, contains lactoferrin and growth factor, along with other lower-weight proteins that are beneficial to human immune system function. This is probably why colostrum has been referred to as "the original transfer factor."
Specific vs. Non-Specific / Standardization
To understand transfer factors, you
first to understand the difference between non-specific (or general) transfer
factors and those which are specifically designed to address a condition.
This is an important part of educating the consumer, because there is
a great difference in production cost (and therefore subsequent
cost in the wholesale and retail markets). Some companies have profited
handsomely because most consumers do not understand the
difference. (This has incentivized the industry, as a whole,
to be quiet, or to downplay the issue, for monetary gain.
We provide our own Transfer
Factor Comparison Chart so that consumers understand
other important factors that affect the efficacy of the
"Treatment" vs. "Pulse Mode"
Researchers in transfer factor
often talk using TF's in immunotherapy modalities versus the infrequent
use of TF's to just "maintain immune health." There is solid research
to support the value of both, given that full immune function relies
on the ability of immune cells to store the "memory" of those two
million plus antigens. While some "loose memory" after three to
five months, others loose this knowledge through repeated cell
replacement so that after so many generations, no cells are left that
"remember" the proper immune response to a specific antigen.
A person who has had previous bouts with a particular illness,
or who may be genetically pre-disposed to a specific disease,
for example, would do well to apply "pulse mode" to a
specific-antigen TF that matches that disease. This usually means
taking the standard dose of that product for one week every three
A Growing Body of International Support
Far from cowering at the fringes
of therapeutic conjecture and universal orthodox derision, TF's as
a legitimate immunotherapy is gaining wide acceptance.
There are now a variety of medical symposiums held yearly
on transfer factor research, much of it devoted to sharing
TF protocols and clinical successes. Six million Chinese people
use transfer factors to help protect against
heptatis. Even in the U.S., TF as an immunotherapy
is covered by Medicare, and legitimate TF treatments
have also been covered by Blue Cross Blue Shield and several
other insurance carriers for years. Veterinary applications
are also making headway with TF products now used to
treat canine parvovirus, Newcastle's disease in chickens,
coccidioides parasites in cattle, and rheumatism
International Transfer Factor Society
Transfer Factor - summary
Immune Therapy Research Laboratory
Credits: Art concept and design, Alternative Medicine magazine (Issue 35: May, 2000).
There are twelve different formulas, all detailed in our Transfer Rx product page. Brief descriptions are provided below:
General Enhance is our own "non-specific" TF formula. It contains low molecular weight whey and colostral fractions, lactoferrin, and alpha lipoic acid to nutritionally support immune function.
Formula One through Formula Eight are "true" transfer factor formulas --- antigen-specific and specifically targeted to particular pathogenic microbes and/or disease conditions. Again, the specificity of each formula is given on the Transfer Rx product page.
Transfer Fact Rx Lozenges, like our "General Enhance" formula, is non-specific. You just place one lozenge per day under the tongue (the taste is not at all unpleasant) and allow to dissolve. This makes taking TF easy and is ideal for those who are observing a "pulsing mode" period where compliance in frequency may be difficult due to a busy lifestyle.
Transfer Fact Rx Elixir is sold by the vial and is accompanied by an injectable syringe for easy extraction. This product is not made or represented as being designed for IM or IV injectible use. The manufacturing of the product is imply made easier by using vial dispensing in the form of the finished product. Sales in the U.S. and Canada will be restricted to medical doctors and authorized researchers, for reasons of legal liability. No other Transfer Fact Rx product will carry this restriction.